Try it
Radiology · Nuclear medicine: radionuclide bone pain therapy
Sample itemWhich radionuclide, an alpha emitter, is approved for castration-resistant prostate cancer with symptomatic bone metastases?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Radium-223
Radium-223 dichloride is a calcium mimetic that targets areas of bone turnover and delivers short-range alpha radiation to metastases, improving survival. Tc-99m and I-123 are diagnostic gamma emitters, and F-18 is a positron emitter used in imaging.
Option by option
A. Technetium-99m
Tc-99m is diagnostic.
B. Fluorine-18
F-18 is a diagnostic positron emitter.
C. Iodine-123
I-123 is diagnostic.
D. Radium-223 (correct)
Correct. Radium-223 is a therapeutic alpha emitter.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Radiology questions
- NeuroimagingWhat is the first investigation of choice in suspected acute subarachnoid haemorrhage?
- Cardiac imagingA 'boot-shaped' heart (coeur en sabot) on a chest radiograph is typical of:
- Musculoskeletal imagingA 'bamboo spine' on a plain radiograph is characteristic of:
- Paediatric radiologyThe 'double bubble' sign on an abdominal radiograph of a newborn suggests: